Clinical trials
Recruiting Carcinoma, Renal Cell trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 3 |
| Merck Sharp & Dohme LLC | 3 |
| Advenchen Pharmaceuticals, LLC. | 1 |
| Arcus Biosciences, Inc. | 1 |
| Calico Life Sciences LLC | 1 |
| Exelixis | 1 |
| Guardant Health, Inc. | 1 |
| Kura Oncology, Inc. | 1 |
| Medicenna Therapeutics, Inc. | 1 |
| Oncorena AB | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 20 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Kidney Neoplasms | 6 |
| Colorectal Neoplasms | 5 |
| Neoplasm Metastasis | 5 |
| Squamous Cell Carcinoma of Head and Neck | 5 |
| Carcinoma, Transitional Cell | 4 |
| Endometrial Neoplasms | 4 |
| Melanoma | 4 |
| Neoplasms | 3 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.